Matinas BioPharma Holdings, Inc.
MTNB · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,274 | $4,527 | $2,645 | $2,482 |
| - Cash | $5,435 | $6,525 | $6,924 | $7,284 |
| + Debt | $2,334 | $2,530 | $2,714 | $2,894 |
| Enterprise Value | $7,173 | $532 | -$1,565 | -$1,908 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$85 | -$2,376 |
| % Margin | – | – | – | – |
| EBITDA | -$2,039 | -$1,824 | -$1,927 | -$3,947 |
| % Margin | – | – | – | – |
| Net Income | -$2,150 | -$5,245 | -$1,656 | -$8,433 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.4 | -1.03 | -0.33 | -1.73 |
| % Growth | 61.2% | -212.1% | 80.9% | – |
| Operating Cash Flow | -$1,474 | -$2,021 | -$2,007 | -$3,510 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,474 | -$2,021 | -$2,007 | -$3,510 |